APO Research
Talk to an analyst

APO RESEARCH · REPORT

Naldemedine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Naldemedine Industry Growth and Trends Forecast to 2032

23 December 202578 pages

Choose your research edition.

Industry ResearchNaldemedine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Naldemedine Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Naldemedine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Naldemedine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Naldemedine Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Naldemedine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Naldemedine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Naldemedine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Naldemedine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Naldemedine include Purdue Pharma and Shionogi among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Naldemedine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Naldemedine market size, estimates, and forecasts are presented in terms of sales volume (k pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Naldemedine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Naldemedine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Naldemedine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Naldemedine Market by Company

Purdue Pharma

Shionogi

Naldemedine Segment by Type

Self-production API

Outsourcing of API

Naldemedine Segment by Application

Clinic

Hospital

Drug Center

Others

Naldemedine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Naldemedine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Naldemedine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Naldemedine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Naldemedine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Naldemedine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Self-production API Table 2. Major Company of Outsourcing of API Table 3. Global Naldemedine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Naldemedine Sales by Type (2021-2026) & (k pcs) Table 5. Global Naldemedine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Naldemedine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Naldemedine Sales Market Share in Value by Type (2021-2026) Table 8. Global Naldemedine Price by Type (2021-2026) & (US$/pcs) Table 9. Global Naldemedine Sales by Type (2027-2032) & (k pcs) Table 10. Global Naldemedine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Naldemedine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Naldemedine Sales Market Share in Value by Type (2027-2032) Table 13. Global Naldemedine Price by Type (2027-2032) & (US$/pcs) Table 14. North America Naldemedine Sales by Type (2021-2026) & (k pcs) Table 15. North America Naldemedine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Naldemedine Sales by Type (2021-2026) & (k pcs) Table 17. Europe Naldemedine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Naldemedine Sales by Type (2021-2026) & (k pcs) Table 19. Asia-Pacific Naldemedine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Naldemedine Sales by Type (2021-2026) & (k pcs) Table 21. Latin America Naldemedine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Naldemedine Sales by Type (2021-2026) & (k pcs) Table 23. Middle East and Africa Naldemedine Sales by Type (2021-2026) & (US$ Million) Table 24. Naldemedine Industry Trends Table 25. Naldemedine Industry Drivers Table 26. Naldemedine Industry Opportunities and Challenges Table 27. Naldemedine Industry Restraints Table 28. Global Naldemedine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Naldemedine Revenue Market Share by Company (2021-2026) Table 30. Global Naldemedine Sales by Company (2021-2026) & (k pcs) Table 31. Global Naldemedine Sales Share by Company (2021-2026) Table 32. Global Naldemedine Market Price by Company (2021-2026) & (US$/pcs) Table 33. Global Naldemedine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Naldemedine Major Company Production Sites and Headquarters Table 35. Global Naldemedine Company, Product Type & Application Table 36. Global Naldemedine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Naldemedine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Naldemedine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Naldemedine Sales by Region (2021-2026) & (k pcs) Table 41. Global Naldemedine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Naldemedine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Naldemedine Sales Market Share in Value by Region (2021-2026) Table 44. Global Naldemedine Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 45. Global Naldemedine Sales by Region (2027-2032) & (k pcs) Table 46. Global Naldemedine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Naldemedine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Naldemedine Sales Market Share in Value by Region (2027-2032) Table 49. Global Naldemedine Sales (k pcs), Value (US$ Million), Price (US$/pcs) and Gross Margin (2027-2032) Table 50. Global Naldemedine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Naldemedine Sales by Application (2021-2026) & (k pcs) Table 52. Global Naldemedine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Naldemedine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Naldemedine Sales Market Share in Value by Application (2021-2026) Table 55. Global Naldemedine Price by Application (2021-2026) & (US$/pcs) Table 56. Global Naldemedine Sales by Application (2027-2032) & (k pcs) Table 57. Global Naldemedine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Naldemedine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Naldemedine Sales Market Share in Value by Application (2027-2032) Table 60. Global Naldemedine Price by Application (2027-2032) & (US$/pcs) Table 61. North America Naldemedine Sales by Application (2021-2026) & (k pcs) Table 62. North America Naldemedine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Naldemedine Sales by Application (2021-2026) & (k pcs) Table 64. Europe Naldemedine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Naldemedine Sales by Application (2021-2026) & (k pcs) Table 66. Asia-Pacific Naldemedine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Naldemedine Sales by Application (2021-2026) & (k pcs) Table 68. Latin America Naldemedine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Naldemedine Sales by Application (2021-2026) & (k pcs) Table 70. Middle East and Africa Naldemedine Sales by Application (2021-2026) & (US$ Million) Table 71. Purdue Pharma Company Information Table 72. Purdue Pharma Business Overview Table 73. Purdue Pharma Naldemedine Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 74. Purdue Pharma Naldemedine Product Portfolio Table 75. Purdue Pharma Recent Development Table 76. Shionogi Company Information Table 77. Shionogi Business Overview Table 78. Shionogi Naldemedine Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 79. Shionogi Naldemedine Product Portfolio Table 80. Shionogi Recent Development Table 81. North America Naldemedine Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 82. North America Naldemedine Sales by Country (2021-2026) & (k pcs) Table 83. North America Naldemedine Sales Market Share by Country (2021-2026) Table 84. North America Naldemedine Sales Forecast by Country (2027-2032) & (k pcs) Table 85. North America Naldemedine Sales Market Share Forecast by Country (2027-2032) Table 86. North America Naldemedine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 87. North America Naldemedine Market Size by Country (2021-2026) & (US$ Million) Table 88. North America Naldemedine Market Share by Country (2021-2026) Table 89. North America Naldemedine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 90. North America Naldemedine Market Share Forecast by Country (2027-2032) Table 91. Europe Naldemedine Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 92. Europe Naldemedine Sales by Country (2021-2026) & (k pcs) Table 93. Europe Naldemedine Sales Market Share by Country (2021-2026) Table 94. Europe Naldemedine Sales Forecast by Country (2027-2032) & (k pcs) Table 95. Europe Naldemedine Sales Market Share Forecast by Country (2027-2032) Table 96. Europe Naldemedine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 97. Europe Naldemedine Market Size by Country (2021-2026) & (US$ Million) Table 98. Europe Naldemedine Market Share by Country (2021-2026) Table 99. Europe Naldemedine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 100. Europe Naldemedine Market Share Forecast by Country (2027-2032) Table 101. Asia-Pacific Naldemedine Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 102. Asia-Pacific Naldemedine Sales by Country (2021-2026) & (k pcs) Table 103. Asia-Pacific Naldemedine Sales Market Share by Country (2021-2026) Table 104. Asia-Pacific Naldemedine Sales Forecast by Country (2027-2032) & (k pcs) Table 105. Asia-Pacific Naldemedine Sales Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific Naldemedine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific Naldemedine Market Size by Country (2021-2026) & (US$ Million) Table 108. Asia-Pacific Naldemedine Market Share by Country (2021-2026) Table 109. Asia-Pacific Naldemedine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. Asia-Pacific Naldemedine Market Share Forecast by Country (2027-2032) Table 111. Latin America Naldemedine Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 112. Latin America Naldemedine Sales by Country (2021-2026) & (k pcs) Table 113. Latin America Naldemedine Sales Market Share by Country (2021-2026) Table 114. Latin America Naldemedine Sales Forecast by Country (2027-2032) & (k pcs) Table 115. Latin America Naldemedine Sales Market Share Forecast by Country (2027-2032) Table 116. Latin America Naldemedine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Latin America Naldemedine Market Size by Country (2021-2026) & (US$ Million) Table 118. Latin America Naldemedine Market Share by Country (2021-2026) Table 119. Latin America Naldemedine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Latin America Naldemedine Market Share Forecast by Country (2027-2032) Table 121. Middle East and Africa Naldemedine Market Size Growth Rate (CAGR) by Country (k pcs): 2021 VS 2025 VS 2032 Table 122. Middle East and Africa Naldemedine Sales by Country (2021-2026) & (k pcs) Table 123. Middle East and Africa Naldemedine Sales Market Share by Country (2021-2026) Table 124. Middle East and Africa Naldemedine Sales Forecast by Country (2027-2032) & (k pcs) Table 125. Middle East and Africa Naldemedine Sales Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa Naldemedine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa Naldemedine Market Size by Country (2021-2026) & (US$ Million) Table 128. Middle East and Africa Naldemedine Market Share by Country (2021-2026) Table 129. Middle East and Africa Naldemedine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Middle East and Africa Naldemedine Market Share Forecast by Country (2027-2032) Table 131. Key Raw Materials Table 132. Raw Materials Key Suppliers Table 133. Naldemedine Distributors List Table 134. Naldemedine Customers List Table 135. Research Programs/Design for This Report Table 136. Authors List of This Report Table 137. Secondary Sources Table 138. Primary Sources List of Figures Figure 1. Naldemedine Image Figure 2. Global Naldemedine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Naldemedine Market Size (2021-2032) & (US$ Million) Figure 4. Global Naldemedine Sales (2021-2032) & (k pcs) Figure 5. Self-production API Image Figure 6. Global Self-production API Sales YoY Growth (2021-2032) & (k pcs) Figure 7. Outsourcing of API Image Figure 8. Global Outsourcing of API Sales YoY Growth (2021-2032) & (k pcs) Figure 9. Global Naldemedine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Naldemedine Market Share by Type 2025 VS 2032 Figure 11. North America Naldemedine Sales Market Share in Volume by Type in 2025 Figure 12. North America Naldemedine Sales Market Share in Value by Type in 2025 Figure 13. Europe Naldemedine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Naldemedine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Naldemedine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Naldemedine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Naldemedine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Naldemedine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Naldemedine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Naldemedine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Naldemedine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Clinic Image Figure 24. Global Clinic Sales YoY Growth (2021-2032) & (k pcs) Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k pcs) Figure 27. Drug Center Image Figure 28. Global Drug Center Sales YoY Growth (2021-2032) & (k pcs) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k pcs) Figure 31. Global Naldemedine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Naldemedine Market Share by Application 2025 VS 2032 Figure 33. North America Naldemedine Sales Market Share in Volume by Application in 2025 Figure 34. North America Naldemedine Sales Market Share in Value by Application in 2025 Figure 35. Europe Naldemedine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Naldemedine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Naldemedine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Naldemedine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Naldemedine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Naldemedine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Naldemedine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Naldemedine Sales Market Share in Value by Application in 2025 Figure 43. North America Naldemedine Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 44. North America Naldemedine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Naldemedine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Naldemedine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Naldemedine Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 48. Europe Naldemedine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Naldemedine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Naldemedine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Naldemedine Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 52. Asia-Pacific Naldemedine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Naldemedine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Naldemedine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Naldemedine Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 56. Latin America Naldemedine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Naldemedine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Naldemedine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Naldemedine Sales by Country: 2021 VS 2025 VS 2032 (k pcs) Figure 60. Middle East and Africa Naldemedine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Naldemedine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Naldemedine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Naldemedine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Naldemedine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Self-production API
  • Outsourcing of API
Applications
  • Clinic
  • Hospital
  • Drug Center
  • Others
Companies covered
  • Purdue Pharma
  • Shionogi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Naldemedine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Naldemedine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Naldemedine Market by Type
  6. 1.3.1 Self-production API
  7. 1.3.2 Outsourcing of API
  8. 1.4 Global Naldemedine Market Size by Type
  9. 1.4.1 Global Naldemedine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Naldemedine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Naldemedine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Naldemedine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Naldemedine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Naldemedine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Naldemedine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Naldemedine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Naldemedine Industry Trends
  2. 2.2 Naldemedine Industry Drivers
  3. 2.3 Naldemedine Industry Opportunities and Challenges
  4. 2.4 Naldemedine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Naldemedine Revenue (2021-2026)
  2. 3.2 Global Top Players by Naldemedine Sales (2021-2026)
  3. 3.3 Global Top Players by Naldemedine Price (2021-2026)
  4. 3.4 Global Naldemedine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Naldemedine Major Company Production Sites & Headquarters
  6. 3.6 Global Naldemedine Company, Product Type & Application
  7. 3.7 Global Naldemedine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Naldemedine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Naldemedine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Naldemedine Tier 1, Tier 2, and Tier 3
4 Naldemedine Regional Status and Outlook
  1. 4.1 Global Naldemedine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Naldemedine Historic Market Size by Region
  3. 4.2.1 Global Naldemedine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Naldemedine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Naldemedine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Naldemedine Forecasted Market Size by Region
  7. 4.3.1 Global Naldemedine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Naldemedine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Naldemedine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Naldemedine by Application
  1. 5.1 Naldemedine Market by Application
  2. 5.1.1 Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Drug Center
  5. 5.1.4 Others
  6. 5.2 Global Naldemedine Market Size by Application
  7. 5.2.1 Global Naldemedine Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Naldemedine Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Naldemedine Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Naldemedine Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Naldemedine Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Naldemedine Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Naldemedine Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Naldemedine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Purdue Pharma
  2. 6.1.1 Purdue Pharma Company Information
  3. 6.1.2 Purdue Pharma Business Overview
  4. 6.1.3 Purdue Pharma Naldemedine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Purdue Pharma Naldemedine Product Portfolio
  6. 6.1.5 Purdue Pharma Recent Developments
  7. 6.2 Shionogi
  8. 6.2.1 Shionogi Company Information
  9. 6.2.2 Shionogi Business Overview
  10. 6.2.3 Shionogi Naldemedine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shionogi Naldemedine Product Portfolio
  12. 6.2.5 Shionogi Recent Developments
7 North America by Country
  1. 7.1 North America Naldemedine Sales by Country
  2. 7.1.1 North America Naldemedine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Naldemedine Sales by Country (2021-2026)
  4. 7.1.3 North America Naldemedine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Naldemedine Market Size by Country
  6. 7.2.1 North America Naldemedine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Naldemedine Market Size by Country (2021-2026)
  8. 7.2.3 North America Naldemedine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Naldemedine Sales by Country
  2. 8.1.1 Europe Naldemedine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Naldemedine Sales by Country (2021-2026)
  4. 8.1.3 Europe Naldemedine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Naldemedine Market Size by Country
  6. 8.2.1 Europe Naldemedine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Naldemedine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Naldemedine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Naldemedine Sales by Country
  2. 9.1.1 Asia-Pacific Naldemedine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Naldemedine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Naldemedine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Naldemedine Market Size by Country
  6. 9.2.1 Asia-Pacific Naldemedine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Naldemedine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Naldemedine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Naldemedine Sales by Country
  2. 10.1.1 South America Naldemedine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Naldemedine Sales by Country (2021-2026)
  4. 10.1.3 South America Naldemedine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Naldemedine Market Size by Country
  6. 10.2.1 South America Naldemedine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Naldemedine Market Size by Country (2021-2026)
  8. 10.2.3 South America Naldemedine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Naldemedine Sales by Country
  2. 11.1.1 Middle East and Africa Naldemedine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Naldemedine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Naldemedine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Naldemedine Market Size by Country
  6. 11.2.1 Middle East and Africa Naldemedine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Naldemedine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Naldemedine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Naldemedine Value Chain Analysis
  2. 12.1.1 Naldemedine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Naldemedine Production Mode & Process
  7. 12.2 Naldemedine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Naldemedine Distributors
  10. 12.2.3 Naldemedine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst